ICh Q10 | Community Health

ICh Q10 is a guideline for pharmaceutical development that emphasizes quality by design, a concept first introduced by Joseph M. Juran. The guideline, developed by the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), provides a framework for ensuring the quality of pharmaceuticals throughout their lifecycle. By adopting a quality-by-design approach, manufacturers can identify and control critical parameters that affect product quality, reducing the risk of quality issues and improving patient safety. The ICH Q10 guideline has been widely adopted by regulatory agencies, including the U.S. Food and Drug Administration (FDA), and has played a crucial role in advancing the quality of pharmaceuticals globally. With its focus on proactive quality management, ICH Q10 has become a cornerstone of modern pharmaceutical development, enabling companies like [[pfizer|Pfizer]] and [[johnson-and-johnson|Johnson & Johnson]] to produce high-quality medicines that meet the needs of patients worldwide. As the pharmaceutical industry continues to evolve, the principles of ICH Q10 remain essential for ensuring the quality and safety of medicines, and its impact can be seen in the work of organizations like [[who|World Health Organization]] and [[ema|European Medicines Agency]].